Poehling Capital Management, Inc. Bausch Health Companies Inc. Transaction History
Poehling Capital Management, Inc.
- $366 Million
- Q2 2024
A detailed history of Poehling Capital Management, Inc. transactions in Bausch Health Companies Inc. stock. As of the latest transaction made, Poehling Capital Management, Inc. holds 87,961 shares of BHC stock, worth $719,520. This represents 0.17% of its overall portfolio holdings.
Number of Shares
87,961
Previous 88,043
0.09%
Holding current value
$719,520
Previous $934,000
34.37%
% of portfolio
0.17%
Previous 0.25%
Shares
18 transactions
Others Institutions Holding BHC
# of Institutions
272Shares Held
280MCall Options Held
5.68MPut Options Held
17.4M-
Icahn Carl C Sunny Isles Beach, FL34.7MShares$284 Million2.24% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny26.4MShares$216 Million14.13% of portfolio
-
Goldentree Asset Management LP New York, NY22.4MShares$184 Million15.5% of portfolio
-
Nomura Holdings Inc Tokyo, M019.4MShares$158 Million0.27% of portfolio
-
National Bank Of Canada15.7MShares$128 Million0.17% of portfolio
About Bausch Health Companies Inc.
- Ticker BHC
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 361,728,000
- Market Cap $2.96B
- Description
- Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...